Skip to content

Type: White Papers

White Paper | Outdated Prescription Drug Labeling: How FDA-Approved Prescribing Information Lags Behind Real-World Clinical Practice

White Paper | Early Evaluation of Molecularly Targeted Therapies for Childhood and Adolescent Cancer

White Paper | Charting the Course for Precision Medicine: Adopting Consensus Analytical Standards and Streamlining Approval Pathways for Post-Market Modifications for NGS Tests in Oncology

White Paper | 2017 Annual Meeting | Data Generation to Support Cross-labeling of Indications for Combination Products

White Paper | 2017 Annual Meeting | Updating Outdated Product Labels

White Paper | 2017 Annual Meeting | Capitalizing on the Totality of Evidence to Streamline Approvals for Supplemental Indications

White Paper | Streamlining Approval of Supplemental Indications

White Paper | Trends in the Molecular Diagnosis of Lung Cancer: Results from an Online Market Research Survey

White Paper | Accelerating Pediatric Drug Development – Session 1 | Challenges & Opportunities in Pediatric Oncology Drug Development

White Paper | 2016 Annual Meeting | Optimization of Exploratory Randomized Trials